Compounds which bind to opioid receptors are provided. In a preferred embodiment of the invention, the compounds are opioid receptor antagonists. The present invention also provides methods of treating conditions which are mediated by an opioid receptor.
Octahydroisoquinoline compounds as opioid receptor modulators
Carroll, F., Navarro, H., Mascarella, S., & Thomas, J. (2009). IPC No. U.S. Octahydroisoquinoline compounds as opioid receptor modulators. (U.S. Patent No. 7476679).
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.